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Abstract
In previous studies, patients with probable Alzheimer’s
disease (AD) have indicated that they experienced less
pain intensity and affect from their painful conditions
than nondemented elderly persons. However, in those
studies, pain assessment occurred only once. Therefore,
it may be possible that pain which had occurred, for
example, a day earlier, could have been forgotten.
Therefore, in the present study, AD patients’ pain was
assessed daily, i.e. once a day and even three times a
day, during a longer period. The results parallel those of
earlier studies, i.e. compared to elderly persons without
dementia, AD patients appear to perceive less pain inten-
sity and pain affect. These findings support the hypothe-
sis that AD is characterized by an alteration in pain expe-
rience.
Copyright © 2001 S. Karger AG, Basel
An increasing number of studies underscore the prob-
lem of pain assessment in cognitively impaired elderly
persons [1–3]. It has been observed that 83% of cognitive-
ly impaired patients could complete at least one out of
seven pain scales [4]. Also, self-reports could be validly
used in assessing pain in cognitively impaired patients [5].
Parmelee et al. [5] observed that the more people become
cognitively impaired, the less they report pain. Since in
both studies [4, 5] the precise diagnosis of the participat-
ing subjects was unclear, the observed relationship be-
tween cognition and pain remains obscure.
Alzheimer’s disease (AD) is characterized by atrophy
in the limbic areas, e.g. the septohippocampal region, the
amygdala, the hypothalamus, and the intralaminar nuclei
of the thalamus [6, 7]; areas which are involved in the
experience of pain [8–10]. In several studies, we therefore
assessed pain experience exclusively in patients with AD.
In a first study, the use of analgesics (nonsteroidal anti-
inflammatory drugs, NSAIDs, and other analgesic medi-
cations) of 70 nondemented elderly persons was com-
pared with the use of these substances in AD patients at
either a mild (n = 14), a moderate (n = 25) or a severe stage
(n = 27) of the disease [11]. The results showed that
although the number of chronic, painful conditions did
not differ between the groups, the nondemented elderly
persons used significantly more NSAIDs and other
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analgesic medications than the AD patients, irrespective
of the stage of the disease. Subsequently, specific parts of
three verbal pain questionnaires, in which memory
played the less important role, were completed by 19 AD
patients and 18 nondemented elderly persons [12]. The
results showed that AD patients indicated that they expe-
rienced less intense pain and less pain affect than the non-
demented elderly persons, despite the fact that both
groups were matched for the presence of chronic painful
conditions and the use of analgesics did not differ be-
tween both groups. The question arose whether these
results reflected an alteration in pain experience in AD or
whether they were due to a decline in the patients’ ability
to communicate about their pain. In order to enhance
communication about pain, several simple visual ana-
logue scales which are used in pediatrics were applied to
20 AD patients at a relatively early stage, 20 AD patients
at midstage and 20 elderly persons without dementia [13].
Only the subjects who comprehended the concept of the
scale were included in the data analyses. The results of
that study showed that elderly persons without dementia
reported experiencing more intense pain and pain affect
from their own painful conditions than the early and mid-
stage AD group. The latter two groups did not differ as far
as reporting pain affect was concerned. Eliminating the
influence of communicative disorders on pain assessment
strengthens the hypothesis that one of the clinical symp-
toms in AD could be an alteration in pain experience.
It is noteworthy that in the above-mentioned studies
pain assessment took place only once, and one cannot,
thus, exclude the possibility that the AD patient who had
suffered pain, e.g. a day or several hours before the assess-
ment took place, just could not remember it. The septo-
hippocampal region and the amygdala play a well-known
role in memory processes as well [14–16]. One of the
greatest confounding variables in pain assessment in de-
mented people is the influence of a decline in memory for
pain on pain assessment [10]. In the present study AD
patients and nondemented elderly persons underwent
repeated pain assessment. One condition was that the
subject’s pain was assessed once a day during 4 weeks and,
2 months later, again for a period of 5 days. After careful
verification that the daily visits of the researcher did not
upset the subjects (e.g., the doctor visits me every day so I
am probably very ill), a second condition was included in
which pain assessment took place at three different mo-
ments of the day, for 5 days.
Methods
Condition 1
Pain was assessed once a day, during 4 weeks and 2 months later
for a period of 5 days.
Subjects. The sample consisted of two groups: 14 AD patients (12
females, 2 males) at a relatively early stage, i.e. stage 5 of the Global
Deterioration Scale [17], and 17 elderly persons without dementia
(14 females, 3 males). Gender (¯2 = 0.06, d.f. = 1, NS) and age (Mann-
Whitney U: Z = 0.28, NS) of the two groups did not differ. The AD
patients had a mean age of 87.93 (range 78–99), whereas the mean
age of the nondemented elderly persons was 87.41 (range 78–97).
The AD group and the nondemented group showed no significant
difference in education (Mann-Whitney U: Z = 0.13, NS; five catego-
ries: elementary school not finished: score = 1; elementary school fin-
ished: score = 2; lower secondary school: score = 3; higher secondary
school: score = 4; higher vocational training for 18+/university:
score = 5): M = 2.36 (range 2–4) and M = 2.41 (range 2–4), respectively.
All AD patients met the NINCDS-ADRDA criteria for the clini-
cal diagnosis of probable AD [18]. Subjects were excluded from par-
ticipation in this study if they had problems with vision, a history of
psychiatric disorder (e.g. depression), alcoholism, cerebral trauma,
cerebrovascular disease, hydrocephalus, neoplasm, epilepsy, distur-
bances of consciousness, or focal brain disorders.
The level of cognitive functioning was assessed by using a short-
ened 12-item version [19] of the Mini-Mental State Examination
(MMSE) [20]. The 12-item version (maximum score: 12) evaluates
orientation to time and place, registration, recall, attention, and cal-
culation, language and praxis, and visuoconstructive abilities [19]. A
score of 7–10, which is comparable to a score of 18–24 of the 20-item
MMSE version (maximum score 30) [19], indicates mild cognitive
deterioration. The mean score of the control group and the AD group
appeared to be 10.18 (range 7–12) and 7.43 (range 6–9), respectively,
resulting in a significant difference (Mann-Whitney U: Z = 4.04; p !
0.000).
Characteristics of Painful Conditions. The two groups were
matched for chronic painful conditions, i.e. painful conditions with a
duration of at least 6 months. Separate conditions which might cause
pain for those with and without dementia were collected by one of the
authors (E.J.A.S.) by reviewing their former general practitioner’s
records and those held by the present nursing home physician. These
medical records included the subjects’ medical history and their
present mental and physical status. Reports from the neurologist,
orthopedist, psychiatrist, and neuropsychologist were added. The fol-
lowing three categories of painful conditions emerged: (1) arthritis/
arthrosis; (2) recent fractures (within the last year), and (3) miscella-
neous (e.g. tendinitis and diabetes neuropathia). These painful condi-
tions are similar to those generally observed in nursing home resi-
dents [1]. In the present study, the AD group and nondemented
group had either one (85.7 and 82.4%, respectively) or two painful
conditions (14.3 and 17.6%, respectively). The AD group and the
nondemented group did not appear to differ as far as the number of
chronic painful conditions was concerned (Mann-Whitney U: Z =
0.25; NS). The AD group and the nondemented group did not differ
in the prevalence of arthritis (85.7 and 94.1%, respectively; ¯ 2 = 0.62,
d.f. = 1, NS), recent fractures (14.3 and 5.9%, respectively; ¯ 2 = 0.62,
d.f. = 1, NS) and miscellaneous (14.3 and 17.6%, respectively; ¯2 =
0.06, d.f. = 1, NS).
Comorbidity. The prevalence of specific categories of illness in
demented and nondemented subjects was ascertained to assess
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whether the patients in the latter group have diseases which might
contribute to their pain experience. Specific categories of illness
included congestive heart failure, peripheral vascular disease,
chronic pulmonary disease, diabetes mellitus, chronic renal failure,
tumors, ulcers, anemia, hyper-hypothyroidism, cholecystectomy,
hearing and vision problems, urology, hypertension, Dupuytren’s
disease, migraine, diverticulosis, esophagitis, liver disturbances,
prostatism, strumectomy, and dizziness. For each separate category
of illness, comparisons were made between the two groups, using ¯2
tests. Only cholecystectomy occurred with a significantly higher fre-
quency in the nondemented group (30%) as compared to the AD
group (0%; ¯ 2 = 4.91, d.f. = 1, p ! 0.03). Subsequently, the number of
disorders was compared between the two groups. The results re-
vealed that the number of illnesses did not differ between the two
groups (Mann-Whitney U: Z = 1.73; NS).
Use of NSAIDs and Other Analgesic Medication
The researcher (E.J.A.S.) who reviewed the records was not
informed about the subjects’ medication status. The nursing home
pharmacist, who did not know the purpose of the study, selected the
most frequently prescribed NSAIDs (ibuprofen, Voltaren, Arthrotec,
diclofenac, naproxyn) and other analgesic medication (paracetamol,
tramadol, caffeine and codeine), and summarized the type and num-
ber of these drugs used by each subject over a period of 8 months. For
overall drug use, the difference between the number of nondemented
subjects (82.4%) and the number of AD patients (50%) showed a
trend (¯2 = 3.68, d.f. = 1, p ! 0.06). More specifically, with respect to
the use of NSAIDs, the number of AD persons (7.1%) and the num-
ber of nondemented elderly persons (23.5%) did not significantly dif-
fer (¯2 = 1.52, d.f. = 1, NS). However, the number of AD patients
(42.9%) using other analgesic medication was significantly lower
than the number of nondemented elderly persons (76.5%; ¯2 = 3.66,
d.f. = 1, p ! 0.03).
Condition 2
Two months after condition 1, pain was assessed three times a
day, during 5 days.
Subjects. In the 2 months following condition 1, the number of
subjects in each group was considerably reduced, due to death and
noncompliance. From the original 14 AD patients, 11 patients (9
women, 2 men) could be included (3 persons died), and from the
original 17 nondemented elderly persons, only 9 subjects (7 women,
2 men) could still participate (3 subjects died, 5 subjects had to be
excluded for noncompliance).
Data analyses revealed that the AD and nondemented group in
condition 2 did not differ in gender (¯2 = 0.06, d.f. = 1, NS), age (M =
87.45 and 87.78, respectively; Mann-Whitney U: Z = 0.12; NS) and
education (M = 2.36 and 2.56, respectively; Mann-Whitney U: Z =
0.43; NS). The AD and nondemented group showed a significant dif-
ference in MMSE scores (M = 7.64 and 10, respectively; Mann-Whit-
ney U: Z = 3.13; p ! 0.001).
Characteristics of Painful Conditions. The subjects of the AD
group and the control group had either one (81.8 and 88.9%, respec-
tively) or two painful conditions (18.2 and 11.1%, respectively). The
data showed no significant differences between the AD group and the
nondemented elderly group for the total number of pain areas (¯2 =
0.19, d.f. = 1, NS), prevalence of arthritis (90.9 and 100%, respective-
ly; ¯2 = 0.86, d.f. = 1, NS), recent fractures (9.1 and 11.1%, respec-
tively; ¯2 = 0.02, d.f. = 1, NS) and the category miscellaneous (0 and
18.2%, respectively; ¯2 = 1.82, d.f. = 1, NS).
Fig. 1. CAS to rate pain intensity. a Front of the CAS as seen by the
subjects. b Back of the CAS which shows the numerical value of the
rating shown on the CAS. Reprinted from McGrath et al. [21] with
permission from Elsevier Science.
Comorbidity. The participating AD patients and the nonde-
mented elderly persons did not show significant differences, either in
the total number of illnesses (¯2 = 9.03, d.f. = 6, NS), or in the sepa-
rate categories of illnesses, except for cholecystectomy (0 and 44.4%,
respectively; ¯ 2 = 6.11, d.f. = 1, p ! 0.02).
Use of NSAIDs and Other Analgesic Medication. Condition 2
occurred 2 months later; during this period no changes in medication
occurred. The difference between the number of AD patients
(45.5%) and the number of nondemented elderly persons using drugs
(88.9%) appeared to be significant (¯2 = 4.10, d.f. = 1, p ! 0.05). With
respect to the use of NSAIDs, no significant difference was observed
between the number of AD patients (9.1%) and the number of elderly
persons without dementia (11.1%; ¯2 = 0.02, d.f. = 1, NS). Further-
more, the number of AD patients using other analgesic medication
(36.4%) significantly differed from the number of nondemented
elderly people taking these drugs (88.9%; ¯2 = 5.69, d.f. = 1, p !
0.01).
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Fig. 2. The FPS. Reprinted from Bieri et al.
[22] with permission from Elsevier Science.
Materials and Procedure
To assess pain intensity and pain affect, three visual analogue
scales, one verbal pain questionnaire and one observation scale were
used.
Visual Analogue Scales. The results of a former study indicated
that visual analogue scales which were originally developed for young
children can be reliably administered to AD patients [13]. Therefore,
in the present study, the following scales were used: (i) the Coloured
Analogue Scale for the assessment of pain intensity (CAS) [21] (fig. 1),
(ii) the CAS for the assessment of pain affect and (iii) the Faces Pain
Scale (FPS) (fig. 2). The CAS is designed to assess, in a nonverbal
manner, the intensity of pain which subjects experience. The CAS
looks like a thermometer (a triangular shape); the different scale posi-
tions are marked by different colors and areas which facilitate the
subject’s selection of a scale position which best reflects the intensity
of his/her pain [21]. Selecting the appropriate scale position is done
by sliding a horizontal marker from the bottom (no pain) to the top
(maximum pain). The subject’s score is the numerical value on the
back of the scale which matches the selected scale position (range
0–100). This scale appears to be suitable to AD patients, since in a
former study all early-stage AD patients and all nondemented elderly
persons fully comprehended the concept of the CAS [13].
In the present study, the CAS [21] (fig. 1) was also used to assess
pain affect, i.e. the extent of suffering from the subject’s own painful
condition(s). The label ‘no pain’ at the bottom was replaced by the
label ‘no suffering’ and the label ‘maximum pain’ at the top by the
label ‘a great deal of suffering’. Similar to the original CAS, each scale
position referred to a number (a numerical value) which was on the
back of the scale. The subject’s scores ranged from 0 to 100.
The FPS (fig. 2) primarily measures the severity of pain and pos-
sibly, to a lesser extent, its affective components [22]. The FPS con-
sists of line drawings of seven faces, i.e. one neutral face and six faces
that express increasing feelings of pain. Each face is 6 cm high. The
faces are rank ordered from 0 to 6, from left to right. Subjects could
rank their feelings from ‘no pain’ (score 0, the neutral face, at the
extreme left side), to the most severe pain (score 6, the face express-
ing the most feelings of pain, at the extreme right side). The subject’s
score is identical to the scale number, i.e. ranging from 0 to 6. In the
former study, all nondemented elderly persons and 60% of the AD
patients at an early stage fully comprehended the concept of the scale
[13].
The Number of Words Chosen-Affective (NWC-A; McGill Pain
Questionnaire) [23]; Dutch language version [24]. This affective pain
scale consists of five items, each of which with three affective adjec-
tives. The items are arranged by increasing intensity (ranking), which
allows the subjects to indicate the nature of the pain (e.g. worry,
depression). The adjectives of the NWC-A were read aloud by the
examiner. By adding the results of this scale, a maximum score of 15
could emerge.
The Feldt Checklist of Nonverbal Pain Indicators (CNPI) [25].
This observation scale is a revised version of the University of Alaba-
ma Pain Behavior Scale [26]. The scale includes the following five
nonverbal behaviors: (1) nonverbal vocalizations, e.g. moans, groans,
grunts, cries; (2) grimacing, e.g. furrowed brow, narrowed eyes, tigh-
tened; (3) bracing, e.g. clutching or holding onto side rails, bed;
(4) restlessness, e.g. constant or intermittent shifting of position, and
(5) rubbing, i.e. massaging the affected area. In addition, the pres-
ence/absence of verbal pain indicators were recorded: verbal vocal-
izations (a verbal descriptor subscale), e.g. ‘that hurts’, cursing during
movement [25]. The interrater reliability ranges from 0.625 to 0.819
for individual items (Î statistics) [25]. A Spearman correlation of the
five nonverbal subscales of the CNPI with the verbal descriptor sub-
scale is r = 0.428 (p ! 0.0001) for a nondemented group (n = 32) and
r = 0.426 (p ! 0.009) for a demented group (n = 32) [25]. In the
present study, the examiner observed the presence/absence of the
pain behavior(s) during standing up, walking and sitting down, with
or without an aid. The score on each items is 0 if the behavior is
absent and 1 if the score is present. Maximum score is 6.
Administration of Scales
Frequency
Condition 1. First, all scales were administered during 4 weeks in
succession, once a day (long-term assessment: LTA-1), 5 days a week,
resulting in 20 measurements of pain experience. If the subject was
absent during the week, pain was assessed at the weekend. In order to
exclude the possibility that pain assessment had taken place in a peri-
od which happened to be very painful or not painful at all, pain
assessment was repeated after a period of approximately 2 months.
However, this second pain assessment period was shorter, i.e. 5 days
in succession, once a day (short-term assessment: STA-1). From a
practical point of view, shortening the assessment period from 1
month to 1 week made it possible to examine whether the data col-
lected within 1 week were comparable to the data collected within 1
month.
Condition 2. After 2 months, pain assessment took place at three
varying, random times a day, again on 5 successive days (STA-3).
Comprehension of the Scales
Each time the scale was administered, subjects were tested for
their comprehension of the concept. For the original CAS and for the
CAS used for the assessment of pain affect they were asked to indi-
cate at what level the marker should be positioned when a person had
the most severe pain/suffered the most (top of the scale) or no pain at
all/no suffering (bottom of the scale). For the FPS, they were asked to
indicate which face showed the most pain and which face showed the
least pain. For the LTA-1, STA-1, and STA-3 the maximum scores
on all three scales were 20, 5, and 15, respectively.
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Pain Experience
On the CAS the subjects were asked to indicate whether the mark-
er should be if it were to match their own level of pain/suffering, both
at the moment of administration and/or on the preceding 3 h. The
subjects were then asked to point out, on the FPS, the face which best
reflected the pain they experienced at the moment of administration
and/or on the preceding 3 h. For the various periods (LTA-1, STA-1
and STA-3), the mean pain scores of only those subjects who compre-
hended the concept of the scales were calculated.
Data Analyses
The SPSS-PC program [27] was used for statistical analyses,
including ¯ 2 tests and Mann-Whitney U tests. The Bonferroni correc-
tion was applied to the significance level of p ! 0.05, resulting in a
critical value of p ! 0.01.
Results
For each separate scale the data will be presented as
follows: (a) comprehension of the scale, i.e. the number of
correct and false interpretations of the concept of the scale
of the subjects in each group, and (b) report of pain experi-
ence. Only those subjects who correctly interpreted the
meaning of the scale were included in the analyses.
CAS Intensity
Comprehension of the Scale. During both the LTA-1,
the STA-1, and the STA-3 periods, all subjects compre-
hended the concept of the scale, except for 1 subject in the
nondemented group who misinterpreted the concept of
the scale on three different occasions during the LTA-1
period.
Report of Pain Experience. The results show that in all
three periods the nondemented elderly persons experi-
enced significantly more intense pain than the subjects in
the AD group. Noteworthy is that the mean score of the
patients in the nondemented group in the STA-1 period is
considerably lower compared to the mean scores in the
other two assessment periods (table 1). Consequently, us-
ing an analysis of repeated measures within subjects, we
examined whether the mean scores of the subjects without
dementia differed significantly over the three periods.
This appeared not to be the case [F(2,7) = 2.73; NS].
CAS Affect
Comprehension of the Scale. Similar to the CAS inten-
sity scale, the same subject of the nondemented group
misinterpreted the meaning of the CAS affect scale during
the LTA-1 assessment period.
Report of Pain Experience. Furthermore, the results
show that, compared to the AD group, the nondemented
elderly persons indicated that they suffered significantly
more pain affect, irrespective of the assessment period.
FPS
Comprehension of the Scale. Overall, the results indi-
cated that despite the fact that 3 nondemented elderly
persons misinterpreted the meaning of the scale, the FPS
was somewhat better understood by the nondemented
group than by the AD group. Particularly data from the
LTA-1 period showed that the subjects of the nonde-
mented group (M = 19.29; range 12–20) comprehended
the scale more than the AD group (M = 16.79, range 11–
20; Mann-Whitney U: Z = 2.33; p ! 0.05). The subjects
without dementia (M = 4.86; range 4–5) and the AD
patients (M = 4.07, range 2–5) showed no significant dif-
ferences in the STA-1 period (Mann-Whitney U: Z = 1.52;
NS) or in the STA-3 period (M = 14.89, range 14–15, and
M = 13.45, range 6–15, respectively; Mann-Whitney U:
Z = 0.55; NS).
Report of Pain Experience. Elderly persons without
dementia reported experiencing significantly more pain
than the AD patients during the three periods (table 1).
NWC-A
The data (table 1) indicate a significant difference
between both groups, i.e. the nondemented elderly per-
sons reported that they experienced much more affective
components of pain than the AD patients, again in all the
three periods LTA-1, STA-1, and STA-3.
CNPI
As indicated in table 1, in both the LTA-1 and STA-3
periods, the nondemented elderly persons showed some-
what more expression of pain than the subjects of the AD
group, but the difference between the groups did not
appear to be significant.
Discussion
Comprehension of the Scales
The Original CAS for Pain Intensity and the CAS for
Pain Affect. The results of the present study show that,
irrespective of the duration of the assessment period
(LTA-1, LTA-2, STA-3), all AD patients interpreted cor-
rectly the meaning of the original CAS for pain intensity
and the CAS in assessing pain affect [13].
This finding supports the suggestion that the CAS is a
valuable instrument in assessing both quantitative (inten-
sity) and qualitative (affect) components of pain in cogni-
Pain experience
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Table 1. Means (M), standard error of the means (SE) and Mann-Whitney U tests of the various pain scales (one
tailed)
Pain scales Nondemented elderly
persons
M SE n
AD patients
M SE n
Mann-Whitney
U tests
Z p
CAS intensity LTA-1 42.54 4.45 17 2.94 1.31 14 4.62 0.000
CAS intensity STA-1 28.21 5.29 14 3.11 1.91 14 4.01 0.000
CAS intensity STA-3 43.59 7.47 9 1.26 1.10 11 3.94 0.000
CAS affect LTA-1 33.33 4.20 17 1.71 0.81 14 4.56 0.000
CAS affect STA-1 26.31 5.27 14 1.67 1.14 14 4.24 0.000
CAS affect STA-3 41.36 6.85 9 0.81 0.66 11 3.94 0.000
FPS LTA-1 2.05 0.33 17 0.27 0.15 14 4.12 0.000
FPS STA-1 1.73 0.38 14 0.18 0.12 14 3.81 0.000
FPS STA-3 2.55 0.29 9 0.01 0.01 11 4.02 0.000
NWC-A LTA-1 2.87 0.56 17 0.20 0.10 14 4.28 0.000
NWC-A STA-1 2.20 0.56 14 0.23 0.19 14 4.07 0.000
NWC-A STA-3 3.88 0.86 9 0.08 0.08 11 3.94 0.000
CNPI LTA-1 0.93 0.09 17 0.82 0.09 14 1.71 0.05
CNPI STA-1 0.89 0.09 14 0.80 0.12 14 0.47 0.36
CNPI STA-3 1.11 0.17 9 0.76 0.13 11 1.87 0.06
LTA-1 = Long-term assessment (1 month, once a day); STA-1 = short-term assessment (5 days, once a day);
STA-3 = short-term assessment (5 days, three times a day); CAS = colored analogue scale; FPS = the faces pain scale;
NWC-A = number of words chosen – affective; CNPI = the Feldt checklist of nonverbal pain indicators.
tively impaired elderly persons. The same conclusion can
be applied to nondemented elderly persons, despite the
fact that 1 subject was not able to indicate the correct
meaning of the scale in both conditions.
FPS. In contrast to our earlier study in which all non-
demented elderly persons comprehended the purpose of
the FPS [13], here 3 persons without dementia misinter-
preted the meaning of the scale on various occasions dur-
ing the LTA-1 assessment period. It should be noted, how-
ever, that in the former study [13] pain assessment
occurred only once, whereas the LTA-1 period in the
present study consisted of 20 assessments. In other words,
the chance of misinterpretation of the scale was consider-
ably enhanced in the present study. Compared to the non-
demented group, a significantly larger number of misin-
terpretations of the FPS was observed in the AD group
during all three assessment intervals. The finding that the
FPS is harder to understand for AD patients than for
elderly people without dementia is consistent with earlier
results [13].
Report of Pain Experience
Independent of the duration of the pain assessment
period (LTA-1, STA-1, STA-3) and the frequency with
which assessment took place (once or three times a day),
the elderly subjects without dementia indicated that they
experienced significantly more pain intensity and pain
affect of their own painful conditions (CAS intensity,
CAS affect, FPS, and NWC-A; table 1) than the AD
patients. It is remarkable that the experience of nonde-
mented elderly persons of pain intensity and, to a lesser
extent, pain affect varied over the three assessment peri-
ods. Such a variation in scores was not observed in the AD
group. In view of the fact that arthritis/arthrosis was the
most prevalent condition in both groups, one could argue
that fluctuations in the inflammatory processes which
underly this joint disease [28] might apparently be better
perceived by the nondemented group than by the AD
group.
Both groups did not significantly differ in their scores
on the CNPI [25]. In the present study, participants
scored on only two variables of the CNPI, one of which
was bracing, e.g. clutching or holding onto side rails and/
or bed. However, this variable appeared to be applicable
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to almost all subjects of both groups because they walked
with an aid. The other nonverbal variable of the CNPI
was grimacing. Particularly furrowed brows were ob-
served in some of the elderly persons without dementia
who also reported high levels of pain intensity and pain
affect. This latter finding might explain the trend which
was found in the LTA-1 and STA-3 intervals (table 1).
Future studies need to examine under which condition
people reporting pain will also score on the other four
variables of the CNPI.
The clinical evidence for an alteration in pain percep-
tion in AD is further supported by studies which exam-
ined AD patients’ responses to experimental pain stimuli.
Compared to nondemented elderly persons, heart rate
increased less in the preparatory phase but increased
more during a standard venipuncture procedure [29].
These findings suggest a blunting of anticipation and
physiological response [29]. Benedetti et al. [30] applied
electrical stimulation and ischemic pain to one arm of AD
patients and nondemented elderly persons. The results
showed that the detection of the electrical stimulus and
the pain threshold for both the electrical stimulation and
the ischemic pain did not differ between the two groups.
However, compared to the nondemented elderly persons,
AD patients showed a significantly higher pain tolerance.
Interestingly, they found that the level of pain tolerance
was inversely related to the cognitive functioning of AD
patients, i.e. the more severe the cognitive decline, the
higher the pain tolerance [30]. Benedetti et al. [30]
observed that increase in pain tolerance was reflected in a
slowing down of the EEG rhythm. It would be worthwile
to examine whether such an EEG pattern is also corre-
lated with a decrease in the clinical experience of pain
intensity and pain affect, as measured by e.g. visual ana-
logue scales. A positive correlation would further support
the reliability of the instruments applied for the assess-
ment of pain in AD.
Finally, although not directly related to pain experi-
ence at first sight, a significantly higher prevalence of cho-
lecystectomy was observed in the nondemented group
compared with the AD group. Interestingly, gallstone for-
mation appears to be enhanced by the apolipoprotein
(apo) E E4 allele [31], a genetically polymorphic protein
which is also a known risk factor for AD [32]. Considering
the role of the apo E E4 allele in both the formation of
gallstones and AD, one might have expected a higher per-
centage of cholecystectomy in AD patients. The opposite
was found here. One explanation might be that the preva-
lence of this protein in the AD group was low. However, if
this assumption is true, one should be careful to generalize
from the present findings. It cannot be excluded that the
observed alteration in pain experience is associated with a
subgroup of AD patients, who do not have the apo E E4
allele. Consequently, a suggestion for future studies on the
influence of AD on pain experience is that one should dif-
ferentiate between AD patients with and without the apo
E E4 allele.
Conclusion
The results of the present study strengthen the hypoth-
esis that AD at a relatively early stage may be accompa-
nied by an alteration in actual pain experience. The role of
the apo E E4 allele in pain experience needs to be further
clarified.
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